Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147620 | SCV000195069 | uncertain significance | Developmental and epileptic encephalopathy, 5 | 2013-03-04 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000724445 | SCV000227789 | uncertain significance | not provided | 2017-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724445 | SCV000243085 | likely benign | not provided | 2021-02-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080124 | SCV000758041 | likely benign | Early infantile epileptic encephalopathy with suppression bursts | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000724445 | SCV001962575 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SPTAN1: BP4, BP7 |
Genome- |
RCV000147620 | SCV002056548 | likely benign | Developmental and epileptic encephalopathy, 5 | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002433635 | SCV002751309 | benign | Inborn genetic diseases | 2019-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |